Only FLASH™ achieves total aorto-ostial stent apposition
- Optimize Patient Outcomes
- Total & Efficient Lesion Coverage
- Streamlined Vessel Reaccess
The Challenge
Suboptimal Lesion Coverage
Standard PTCA catheters are unable to create a smooth transition at the ostium creating suboptimal lesion coverage, which is associated with poor outcomes.1
![flash-vs-standard-of-care@2x flash-vs-standard-of-care@2x](https://ostialflash.com/wp-content/uploads/2020/10/flash-vs-standard-of-care@2x.jpg)
The solution
![Flash3D_NoBackground_02_v2-fade Flash3D_NoBackground_02_v2-fade](https://ostialflash.com//wp-content/uploads/2020/09/Flash3D_NoBackground_02_v2-fade.png)
97%
of lesions demonstrated complete stent apposition2,3
Novel Dual-Balloon Technology
Available for both coronary and peripheral indications.
![flash_01 flash_01](https://ostialflash.com//wp-content/uploads/2020/09/flash_01.jpg)
EASY DELIVERY AND CATHETER POSITIONING
The FLASH system is designed to confidently access and address challenging aorto-ostial stenting, providing total lesion coverage.
![flash_02 flash_02](https://ostialflash.com//wp-content/uploads/2020/09/flash_02.jpg)
TRUE 360° FLARED APPOSITION
Novel 2-in-1 dual balloon design allows for inflation of a non-compliant distal balloon to anchor the system, while inflation of the compliant, low-pressure proximal balloon conforms the stent to the wall of the ostium.
![flash_03 flash_03](https://ostialflash.com//wp-content/uploads/2020/09/flash_03.jpg)
STREAMLINED
REACCESS
With TRUE 360° wall apposition achieved, a smooth transition is created for improved reaccess in future interventions.1,2
confident outcomes
The FLASH System demonstrates consistently low restenosis at 6 months, below the 9% rate reported for accurate stent placement in ostial lesions.6§
Excellent Final Result
RCA Ostial Stenosis
![Picture1 Prior to stent deployment](https://ostialflash.com//wp-content/uploads/2020/09/Picture1.jpg)
![Picture2 Stent protruding into aorta](https://ostialflash.com/wp-content/uploads/2020/09/Picture2.jpg)
![Picture3 Post-dilatation with FLASH](https://ostialflash.com/wp-content/uploads/2020/09/Picture3.jpg)
![full360 TRUE 360° result](https://ostialflash.com/wp-content/uploads/2020/09/full360.jpg)
FEVAR
![Picture-1a Stent protruding into aorta](https://ostialflash.com/wp-content/uploads/2020/09/Picture-1a.jpg)
![Picture-1b Post-dilatation with FLASH](https://ostialflash.com/wp-content/uploads/2020/09/Picture-1b.jpg)
![full360-2 TRUE 360° result](https://ostialflash.com/wp-content/uploads/2020/09/full360-2.jpg)
Resources
Case studies, training videos, and more.
newsroom
Ostial Corporation Appoints Mike Buck as Chief Executive Officer Seasoned Medtech Executive Leads Company into Next Phase of Growth CAMPBELL, CA – July 1, 2024 – Ostial Corporation (Ostial), a private medical technology company focused on addressing the clinical challenges of aorto-ostial interventions, is pleased to announce the appointment of Mike Buck as its new […]
Read MoreProceeds to accelerate commercialization and pipeline expansion of novel FLASH™ Aorto-Ostial Angioplasty System
Ostial Corporation (Ostial), a private medical technology company focused on addressing the clinical challenges of aorto-ostial interventions, today announced the raise of $7.5M in growth funding led by Delos Capital with participation from AMED Ventures and other existing investors.
Ostial Corporation (Ostial), a private medical technology company focused on addressing the clinical challenges of aorto-ostial interventions, today reached a new milestone, passing the mark of 15,000 commercial units sold of its FLASH™ Aorto-Ostial Angioplasty System (FLASH System) in over 300 hospitals across the United States. FLASH is the first and only dual balloon-based system designed for use in aorto-ostial angioplasty in coronary and peripheral cases.
Read MoreFind out more about FLASH™
§compared to non-ostial lesions
- Cook, et al. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation European Heart Journal 2012. 33:1334-1343.
- Data on file at Ostial Corporation.
- Sanghvi K, Morris T, Kovach R. Optimal Aorto-ostial Lesion Treatment With Flash Ostial Balloon Is Feasible and Safe. JACC. 2016;9(4). Supplement S.
- Nguyen-Trong P, Martinez Parachini J, Resendes E, et al. Procedural Outcomes With Use of the Flash Ostial System in Aorto-Coronary Ostial Lesions. Catheter Cardiovasc Interv.
2016;88(7):1067-1074. - Data on file at Ostial Corporation.
- Dishmon D, Elhaddi A, Packard K, et al. High Incidence of Inaccurate Stent Placement in the Treatment of Coronary Aorto-Ostial Disease. JIC. 2011;23(8).
Indications, Contraindications, Warnings & Precautions
The FLASH™ Ostial system in a specialty balloon device and should only be used by physicians who are trained to use it.
To request a complete copy of the IFU or user training, please contact customer service at customerservice@ostialflash.com.